Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT.

European journal of nuclear medicine and molecular imaging·2026
Same author

Microwave-Assisted Rapid Extraction of Oleuropein from Olive Leaf By-Product and Processing into Oleuropein@Zeolite Nanohybrids for Antioxidant Food Applications (Fortified Salt and Active Gelatin Films).

Molecules (Basel, Switzerland)·2026
Same author

Interpreting [<sup>18</sup>F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trial.

European journal of nuclear medicine and molecular imaging·2026
Same author

Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [<sup>1</sup>⁸F]FDG PET/CT metrics in metastatic melanoma.

European journal of nuclear medicine and molecular imaging·2026
Same author

Casein-Lecithin Nanoemulsions Co-Encapsulating Vitamin E and Carvacrol as Multifunctional Edible Coatings for Meat Preservation.

Gels (Basel, Switzerland)·2026
Same author

Architecture Effect on Network Phase Formation from Controlled Self-Assembly of High‑χ Block Copolymers.

Macromolecules·2026

Related Experiment Video

Updated: Mar 3, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.8K

Rational Design of New Biocompatible Near-Infrared Conjugated Polymer Nanoparticles for Biomedical Applications.

Aristea Pavlou1,2,3, Athanasios Katsouras2,4, Maria Markou2

  • 1Institute of Chemical Biology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, Athens 11635, Greece.

Macromolecules
|March 2, 2026
PubMed
Summary

New conjugated polymer nanoparticles (CPNs) show promise for cancer theranostics, offering enhanced fluorescence imaging and biocompatibility. This study highlights their potential while emphasizing the need for rational design strategies in CPN development.

More Related Videos

Synthesis of Near-Infrared Emitting Gold Nanoclusters for Biological Applications
09:11

Synthesis of Near-Infrared Emitting Gold Nanoclusters for Biological Applications

Published on: March 22, 2020

8.5K
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

8.9K

Related Experiment Videos

Last Updated: Mar 3, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.8K
Synthesis of Near-Infrared Emitting Gold Nanoclusters for Biological Applications
09:11

Synthesis of Near-Infrared Emitting Gold Nanoclusters for Biological Applications

Published on: March 22, 2020

8.5K
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

8.9K

Area of Science:

  • Nanomaterials Science
  • Biomedical Engineering
  • Organic Chemistry

Background:

  • Conjugated polymer nanoparticles (CPNs) are vital for cancer theranostics, enabling fluorescence imaging and therapy.
  • A gap exists in rational design strategies and structure-property relationships for CPN development.
  • Optimized CPNs are crucial for early cancer detection and image-guided surgery.

Purpose of the Study:

  • To synthesize and characterize novel donor-acceptor (D-A) conjugated polymers (CPs) for CPNs.
  • To evaluate the impact of different donor groups on CPN optical and biological properties.
  • To investigate the cellular uptake mechanism of CPNs in cancer cells.

Main Methods:

  • Synthesis of D-A CPs with varying donor groups.
  • Characterization of CPN optical properties (fluorescence intensity, photostability).
  • In vitro biocompatibility and cellular uptake studies using HCT-116 and HUVEC cells.

Main Results:

  • Synthesized CPNs exhibited enhanced fluorescence intensity in aqueous media and good photostability.
  • CPNs demonstrated nontoxicity, strong fluorescence, and biocompatibility with HCT-116 and HUVEC cells.
  • The study provides the first investigation into the cellular uptake mechanism of CPNs in HCT-116 cells.

Conclusions:

  • Developed CPNs show significant potential as fluorescent contrast agents for HCT-116 cancer imaging.
  • Findings underscore the need for rational design frameworks to advance CPN development.
  • This research contributes to the systematic advancement of CPNs for theranostic applications.